Pharmaceutical Product Monograph: Ampicillin Sodium Injection (500 mg)
In the pharmaceutical industry, Ampicillin is a foundational, moderate-spectrum Beta-lactam antibiotic belonging to the aminopenicillin group. As a pharmacist and manufacturer, I view this molecule as a “Bacterial Cell Wall Disruptor”—it is technically designed to provide broader coverage than Penicillin G, particularly against Gram-negative organisms like H. influenzae and E. coli.
At your WHO-GMP facility in Mumbai, Ampicillin 500 mg injection is a high-demand SKU for Institutional and Emergency Care. While oral ampicillin has largely been replaced by amoxicillin due to better absorption, the injectable (Sodium salt) form remains a critical tool for achieving immediate, high systemic concentrations in acute clinical settings.
Therapeutic Profile: Primary Indications
Ampicillin 500 mg injection is indicated for severe infections caused by susceptible strains of both Gram-positive and Gram-negative bacteria.
| Indication | Clinical Context | Technical Rationale |
| Bacterial Meningitis | CNS Infection | Often used in high-dose combinations (with aminoglycosides) to cross the blood-brain barrier and treat Listeria or GBS. |
| Septicemia | Bloodstream Infection | Used as an empirical intravenous treatment for suspected bacterial sepsis before culture results are available. |
| Gastrointestinal | Typhoid / Shigellosis | Effective against Salmonella typhi and other gut-related pathogens in severe cases. |
| Genitourinary | Severe UTIs | Treats complicated urinary tract infections and kidney infections (pyelonephritis). |
| Endocarditis | Heart Valve Infection | Used for the treatment and prophylaxis of bacterial endocarditis, often in dental or surgical settings. |
Mechanism: Inhibition of Cell Wall Synthesis
Ampicillin exerts its bactericidal effect by interfering with the structural integrity of the bacterial cell:
PBP Binding: The drug binds to specific Penicillin-Binding Proteins (PBPs) located on the inner membrane of the bacterial cell wall.
Peptidoglycan Blockade: It inhibits the final “transpeptidation” step of cell wall synthesis, preventing the cross-linking of peptidoglycan strands.
Lysis: This weakens the cell wall, making it unable to withstand the internal osmotic pressure of the bacterium, which then bursts (osmotic lysis).
The Pharmacist’s “Technical Warning”
The “Anaphylaxis” Protocol: As a pharmacist, I must emphasize that this drug is strictly contraindicated in patients with a known Penicillin Allergy. A skin test is often required for the first IV dose in a hospital setting.
The “Mono” Rash: If ampicillin is mistakenly given to a patient with Infectious Mononucleosis (a viral infection), it will cause a distinctive, non-allergic maculopapular rash.
Stability & Reconstitution: Ampicillin Sodium is highly unstable in solution. Once reconstituted with Water for Injections, it must be used within one hour. Stability decreases even faster in Dextrose-containing fluids.
Sodium Load: Since this is the “Sodium salt” form, patients on strict sodium-restricted diets (e.g., those with Congestive Heart Failure) must have their intake monitored.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Aseptic Powder” USP: On your digital marketplace, highlight your State-of-the-art Aseptic Powder Filling. Ampicillin Sodium is supplied as a sterile dry powder because it degrades rapidly in liquid form. Ensuring a 100% moisture-free, sterile seal is the hallmark of your WHO-GMP compliance.
Cost-Efficiency for Tenders: Standalone Ampicillin 500 mg remains a highly cost-effective option for government health tenders in emerging markets (Africa, SE Asia) compared to newer carbapenems or combinations.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Ampicillin 500 mg and 1 g vials to support your firm’s registration in international B2B hospital supply contracts.